In the second of a two-part series, European patent attorneys at Syngenta and HGF explore contrasting approaches to plausibility in Europe ahead of the G2/21 decision
In the first of a two-part series, European patent attorneys at Syngenta and HGF explore the issues underlying the G2/21 referral and what it all means for rights owners
